Increased risk of biochemical and clinical failure for prostate patients with a large rectum at radiotherapy planning: results from the Dutch trial of 68 GY versus 78 Gy.

[1]  Icru.  Prescribing, recording, and reporting photon beam therapy , 1993 .

[2]  Joos V Lebesque,et al.  Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  J. Montie,et al.  Functional anatomy of the prostate: implications for treatment planning. , 2005, International journal of radiation oncology, biology, physics.

[4]  Radhe Mohan,et al.  Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. , 2005, International journal of radiation oncology, biology, physics.

[5]  W. De Neve,et al.  Magnetic resonance imaging anatomy of the prostate and periprostatic area: a guide for radiotherapists. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  Marcel van Herk,et al.  Target definition in prostate, head, and neck. , 2005, Seminars in radiation oncology.

[7]  J. Manola,et al.  Patient-reported acute gastrointestinal toxicity in men receiving 3-dimensional conformal radiation therapy for prostate cancer with or without neoadjuvant androgen suppression therapy. , 2005, Urologic oncology.

[8]  P. Koper,et al.  Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy. , 2005, International journal of radiation oncology, biology, physics.

[9]  Joos V Lebesque,et al.  Strategies to reduce the systematic error due to tumor and rectum motion in radiotherapy of prostate cancer. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  R. Eeles,et al.  Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects , 2005, British Journal of Cancer.

[11]  W. De Neve,et al.  Intensity-modulated radiotherapy as primary treatment for prostate cancer: acute toxicity in 114 patients. , 2004, International journal of radiation oncology, biology, physics.

[12]  E. B. Butler,et al.  Predictors of Extracapsular Extension and Its Radial Distance in Prostate Cancer: Implications for Prostate IMRT, Brachytherapy, and Surgery , 2003, Cancer journal.

[13]  Joos V Lebesque,et al.  Inclusion of geometric uncertainties in treatment plan evaluation. , 2002, International journal of radiation oncology, biology, physics.

[14]  James D. Cox,et al.  Consensus statement: Guidelines for PSA following radiation therapy , 1997 .

[15]  D. Chan,et al.  The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. , 1993, The Journal of urology.

[16]  M. Herk.  Errors and margins in radiotherapy. , 2004 .

[17]  R. Henriksson,et al.  Acute side effects after dose-escalation treatment of prostate cancer using the new urethral catheter BeamCath technique. , 2001, Acta oncologica.

[18]  D. Low,et al.  A critical evaluation of the planning target volume for 3-D conformal radiotherapy of prostate cancer. , 1998, International journal of radiation oncology, biology, physics.